• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALYDIA HEALTH JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALYDIA HEALTH JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM Back to Search Results
Model Number JADA-1001
Device Problem Migration or Expulsion of Device (1395)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/23/2021
Event Type  malfunction  
Manufacturer Narrative
The user facility did not allege that the device caused or contributed to patient injury or malfunctioned.Jada expulsion was likely secondary to vomiting as reported by the facility.No additional treatment for bleeding was required following the expulsion of the device.No injury or adverse events related to the expulsion of the device were reported.We do not believe that jada malfunctioned based on the information available at this time, but out of an abundance of caution and because we cannot rule it out at this time we are reporting this event due to the 30 day reporting deadline.If we become aware of additional information, we will supplement this report.The submission of this report is not an admission that the device caused or contributed to the reported event.
 
Event Description
The patient was noted to have abnormal postpartum bleeding related to uterine atony after her delivery.Prior to jada insertion she received carboprost (1 dose), methergine (1 dose), and misoprostol.Estimated blood loss at time of jada insertion was noted as 600 ml.The report states jada was inserted, and 10 minutes after treatment was initiated, the patient vomited and expelled the device.The total amount of blood collected in the vacuum canister was noted as 20 ml.The report stated that, "the fundus was determined to be firm without additional bleeding, therefore the team determined not to re-insert the jada device." the total cumulative blood loss for this event was reported at 620 ml and bleeding was controlled.The patient was also reported as having received intrapartum antibiotics as she was positive for group b strep (gbs).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JADA SYSTEM
Type of Device
INTRAUTERINE VACUUM CONTRACTION SYSTEM
Manufacturer (Section D)
ALYDIA HEALTH
3495 edison way
menlo park CA 94025
Manufacturer (Section G)
ALYDIA HEALTH
3495 edison way
menlo park CA 94025
Manufacturer Contact
richard ferrick
3495 edison way
menlo park, CA 94025
8445232666
MDR Report Key12921943
MDR Text Key285062605
Report Number3017425145-2021-00029
Device Sequence Number1
Product Code OQY
UDI-Device Identifier00850017882003
UDI-Public(01)00850017882003
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K201199
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 12/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/03/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberJADA-1001
Device Catalogue NumberJADA-1001
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/03/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/12/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age21 YR
Patient SexFemale
Patient Weight79 KG
Patient EthnicityNon Hispanic
Patient RaceBlack Or African American
-
-